SPA
VCEL icon

Sherbrooke Park Advisers’s Vericel Corp VCEL Stock Holding History

Sherbrooke Park Advisers’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,215
Closed -$233K – 795
2025
Q1 		$233K Buy
+5,215
New +$281K 0.11% 384

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Sherbrooke Park Advisers's VCEL Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Vericel Corp (VCEL) in Q2 2025, closing a stake of 5,215 shares — an estimated $233K sold.

Sherbrooke Park Advisers first reported a position in VCEL in Q1 2025 and held it in 1 quarter. The position peaked at $233K in Q1 2025. 273 funds tracked by Wall St. Rank hold VCEL as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Vericel Corp position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 5,215 Vericel Corp shares in Q2 2025, an estimated $233K.
  • Sherbrooke Park Advisers first reported a position in Vericel Corp in Q1 2025 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Vericel Corp position peaked at $233K in Q1 2025.
  • 273 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.